# The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH

> **NCT03384121** · PHASE1 · UNKNOWN · sponsor: **The Hospital for Sick Children** · enrollment: 5 (estimated)

## Conditions studied

- Idiopathic Infantile Hypercalcemia - Mild Form

## Interventions

- **DRUG:** Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension

## Key facts

- **NCT ID:** NCT03384121
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-22
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2021-08-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03384121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03384121, "The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03384121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*